FDA Inspection
Boston Medical Center CorporationBoston Medical Center Corporation – FDA Inspection, Jan 14, 2010
Record Details
This FDA Inspection record concerns Boston Medical Center Corporation, with an inspection on January 14, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 14, 2010
- Product Type
- Biologics
View Company Profile
ID · 60ffb9f4-e2fe-40fd-b30c-a86279d55d70
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 638735
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Boston Medical Center Corporation
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 2, 2025 | Not classified | New England District Office | |
| September 12, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 16, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 18, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 3, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Boston Medical Center Corporation
- FDA Inspection 1270738 - 2025-05-02
- FDA Inspection 1218229 - 2023-09-12
- FDA Inspection 1091871 - 2019-05-16
- FDA Inspection 963517 - 2016-03-18
- FDA Inspection 864614 - 2014-02-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.